Harvard Bioscience(HBIO) - 2023 Q4 - Earnings Call Presentation

2 Enabling discovery, safety and production of tomorrow's therapeutics NASDAQ: HBIO Q4'23 Earnings Presentation Jim Green, Chairman, President & CEO Jennifer Cote, CFO & Treasurer March 7, 2024 This document contains forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar ...